Survey Conducted Among Early Breast Cancer Patients Treated With Arimidex for Evaluation of Treatment Adherence

Survey and Follow-up of the Treatment Adherence and Medication Habits of Early Breast Cancer Patients on Adjuvant Hormonal Therapy With the Aromatase Inhibitor Arimidex

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01081509

Acronym

ARIADNE

Enrollment

1077

Registered

2010-03-05

Start date

2010-03-31

Completion date

2011-10-31

Last updated

2011-11-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

adherence, early breast cancer, Arimidex, Therapy adherence

Brief summary

The aim of this study is to assess the patient's perception about and willingness to take his or her medication and the influencing factors interfering with taking medication.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Healthy volunteers

Inclusion criteria

* Early breast cancer * Post menopausal * Adjuvant hormonal Arimidex therapy

Design outcomes

Primary

Measure	Time frame
Percent of patients remaining adherent to therapy with Arimidex	Every 3 months

Secondary

Measure	Time frame
Questionnaire for factors influencing adherence	Every 3 months

Countries

Hungary

Outcome results